179 related articles for article (PubMed ID: 35604527)
1. pHLIP Peptides Target Acidity in Activated Macrophages.
Visca H; DuPont M; Moshnikova A; Crawford T; Engelman DM; Andreev OA; Reshetnyak YK
Mol Imaging Biol; 2022 Dec; 24(6):874-885. PubMed ID: 35604527
[TBL] [Abstract][Full Text] [Related]
2. Targeting breast tumors with pH (low) insertion peptides.
Adochite RC; Moshnikova A; Carlin SD; Guerrieri RA; Andreev OA; Lewis JS; Reshetnyak YK
Mol Pharm; 2014 Aug; 11(8):2896-905. PubMed ID: 25004202
[TBL] [Abstract][Full Text] [Related]
3. Multiplexed Imaging Reveals the Spatial Relationship of the Extracellular Acidity-Targeting pHLIP with Necrosis, Hypoxia, and the Integrin-Targeting cRGD Peptide.
Jin ZH; Tsuji AB; Degardin M; Dumy P; Boturyn D; Higashi T
Cells; 2022 Nov; 11(21):. PubMed ID: 36359894
[TBL] [Abstract][Full Text] [Related]
4. pH-sensitive membrane peptides (pHLIPs) as a novel class of delivery agents.
Andreev OA; Engelman DM; Reshetnyak YK
Mol Membr Biol; 2010 Oct; 27(7):341-52. PubMed ID: 20939768
[TBL] [Abstract][Full Text] [Related]
5. Applications of pHLIP Technology for Cancer Imaging and Therapy.
Wyatt LC; Lewis JS; Andreev OA; Reshetnyak YK; Engelman DM
Trends Biotechnol; 2017 Jul; 35(7):653-664. PubMed ID: 28438340
[TBL] [Abstract][Full Text] [Related]
6. Peptides of pHLIP family for targeted intracellular and extracellular delivery of cargo molecules to tumors.
Wyatt LC; Moshnikova A; Crawford T; Engelman DM; Andreev OA; Reshetnyak YK
Proc Natl Acad Sci U S A; 2018 Mar; 115(12):E2811-E2818. PubMed ID: 29507241
[TBL] [Abstract][Full Text] [Related]
7. Targeting acidity in diseased tissues: mechanism and applications of the membrane-inserting peptide, pHLIP.
Deacon JC; Engelman DM; Barrera FN
Arch Biochem Biophys; 2015 Jan; 565():40-8. PubMed ID: 25444855
[TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetic modeling reveals parameters that govern tumor targeting and delivery by a pH-Low Insertion Peptide (pHLIP).
Svoronos AA; Engelman DM
Proc Natl Acad Sci U S A; 2021 Jan; 118(1):. PubMed ID: 33443162
[TBL] [Abstract][Full Text] [Related]
9. Targeting diseased tissues by pHLIP insertion at low cell surface pH.
Andreev OA; Engelman DM; Reshetnyak YK
Front Physiol; 2014; 5():97. PubMed ID: 24659971
[TBL] [Abstract][Full Text] [Related]
10. Aiming the magic bullet: targeted delivery of imaging and therapeutic agents to solid tumors by pHLIP peptides.
Reshetnyak YK; Andreev OA; Engelman DM
Front Pharmacol; 2024; 15():1355893. PubMed ID: 38545547
[TBL] [Abstract][Full Text] [Related]
11. Targeting the Hypoxic and Acidic Tumor Microenvironment with pH-Sensitive Peptides.
Dharmaratne NU; Kaplan AR; Glazer PM
Cells; 2021 Mar; 10(3):. PubMed ID: 33806273
[TBL] [Abstract][Full Text] [Related]
12. pH-Dependent Transmembrane Activity of Peptide-Functionalized Gold Nanostars for Computed Tomography/Photoacoustic Imaging and Photothermal Therapy.
Tian Y; Zhang Y; Teng Z; Tian W; Luo S; Kong X; Su X; Tang Y; Wang S; Lu G
ACS Appl Mater Interfaces; 2017 Jan; 9(3):2114-2122. PubMed ID: 28058834
[TBL] [Abstract][Full Text] [Related]
13. Tumor-Targeted, Cytoplasmic Delivery of Large, Polar Molecules Using a pH-Low Insertion Peptide.
Svoronos AA; Bahal R; Pereira MC; Barrera FN; Deacon JC; Bosenberg M; DiMaio D; Glazer PM; Engelman DM
Mol Pharm; 2020 Feb; 17(2):461-471. PubMed ID: 31855437
[TBL] [Abstract][Full Text] [Related]
14. In Vivo Distribution and Therapeutic Efficacy of Radioiodine-Labeled pH-Low Insertion Peptide Variant 3 in a Mouse Model of Breast Cancer.
Zhang M; Xi Y; Chen H; Hai W; Li B
Mol Imaging; 2022; 2022():7456365. PubMed ID: 35903249
[TBL] [Abstract][Full Text] [Related]
15. Advanced targeted nanomedicine.
Pereira MC; Reshetnyak YK; Andreev OA
J Biotechnol; 2015 May; 202():88-97. PubMed ID: 25615945
[TBL] [Abstract][Full Text] [Related]
16. The pH low insertion peptide pHLIP Variant 3 as a novel marker of acidic malignant lesions.
Tapmeier TT; Moshnikova A; Beech J; Allen D; Kinchesh P; Smart S; Harris A; McIntyre A; Engelman DM; Andreev OA; Reshetnyak YK; Muschel RJ
Proc Natl Acad Sci U S A; 2015 Aug; 112(31):9710-5. PubMed ID: 26195776
[TBL] [Abstract][Full Text] [Related]
17. pHLIP(Var7)-P1AP suppresses tumor cell proliferation in MDA-MB-231 triple-negative breast cancer by targeting protease activated receptor 1.
Yu M; Chen Y; Wang Z; Ding X
Breast Cancer Res Treat; 2020 Apr; 180(2):379-384. PubMed ID: 32034579
[TBL] [Abstract][Full Text] [Related]
18. Tumor treatment by pHLIP-targeted antigen delivery.
DuPont M; Visca H; Moshnikova A; Engelman DM; Reshetnyak YK; Andreev OA
Front Bioeng Biotechnol; 2022; 10():1082290. PubMed ID: 36686229
[TBL] [Abstract][Full Text] [Related]
19. Comparative Study of Tumor Targeting and Biodistribution of pH (Low) Insertion Peptides (pHLIP(®) Peptides) Conjugated with Different Fluorescent Dyes.
Adochite RC; Moshnikova A; Golijanin J; Andreev OA; Katenka NV; Reshetnyak YK
Mol Imaging Biol; 2016 Oct; 18(5):686-96. PubMed ID: 27074841
[TBL] [Abstract][Full Text] [Related]
20. Targeting Bladder Urothelial Carcinoma with pHLIP-ICG and Inhibition of Urothelial Cancer Cell Proliferation by pHLIP-amanitin.
Moshnikova A; Golijanin B; Amin A; Doyle J; Kott O; Gershman B; DuPont M; Li Y; Lu X; Engelman DM; Andreev OA; Reshetnyak YK; Golijanin D
Front Urol; 2022; 2():. PubMed ID: 36439552
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
